171 filings
Page 4 of 9
6-K
u9xspv03
10 May 23
FSD Pharma Inc. 6-K
7:33am
6-K
04442j giaz39
8 May 23
FSD Pharma Inc. 6-K
9:06am
6-K
4smxlb34007k3
17 Apr 23
FSD Pharma Inc. 6-K
9:34am
6-K
nikmze5g74dd
12 Apr 23
FSD Pharma Inc. 6-K
8:30am
6-K
ouxma8igkjj64
31 Mar 23
FSD Pharma Inc. 6-K
8:21pm
6-K
wffkzbx 773
30 Mar 23
Previously Headed Successful Global Expansion Resulting in Dramatic Increase in Sales and 35-Fold Increase in Shareholder Value for Drink Business
8:30am
6-K
8cpzgc14qbzf6ez
22 Mar 23
FSD Pharma Inc. 6-K
8:30am
6-K
g39t51vez
14 Mar 23
FSD Pharma Inc. 6-K
8:30am
6-K
m2xlpyleu5
28 Feb 23
Harrington to provide strategic guidance on FSD Pharma’s pipeline including recently announced alcohol misuse R&D program
8:30am
6-K
x6yae9223dw
21 Feb 23
FSD Pharma Inc. 6-K
6:04am
6-K
gtu 7jx7z
15 Feb 23
FSD Pharma Inc. 6-K
7:31am
6-K
p2ph7umi qe
14 Feb 23
FSD Pharma Inc. 6-K
6:00am
6-K
wi2sr1
7 Feb 23
FSD Pharma Inc. 6-K
8:30am
6-K
qm03z
30 Jan 23
FSD Pharma Inc. 6-K
8:30am
6-K
jf9wg4r
17 Jan 23
Company Seeking to Initiate Phase 1 Clinical Trial for its First-in-Class Multiple Sclerosis Drug Candidate
8:30am
6-K
g2l06cx793 sp3px
13 Jan 23
FSD Pharma Inc. 6-K
8:30am
6-K
cajhc 6ua0
9 Jan 23
FSD Pharma Inc Announces Three Key Additions to Scientific and Clinical Expert Committee
8:36am
6-K
f6pzd1pyf7eiec
6 Jan 23
FSD Pharma Inc. 6-K
8:30am
6-K
s0if11pd0fpzxaxv8
28 Nov 22
FSD Pharma Inc. 6-K
9:08pm
6-K
7wuvnzzq
14 Nov 22
Condensed consolidated interim financial statements
6:02am